Correlation Between Green Cross and Sk Biopharmaceutica

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Green Cross and Sk Biopharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Green Cross and Sk Biopharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Green Cross Lab and Sk Biopharmaceuticals Co, you can compare the effects of market volatilities on Green Cross and Sk Biopharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Green Cross with a short position of Sk Biopharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Green Cross and Sk Biopharmaceutica.

Diversification Opportunities for Green Cross and Sk Biopharmaceutica

0.8
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Green and 326030 is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Green Cross Lab and Sk Biopharmaceuticals Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sk Biopharmaceuticals and Green Cross is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Green Cross Lab are associated (or correlated) with Sk Biopharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sk Biopharmaceuticals has no effect on the direction of Green Cross i.e., Green Cross and Sk Biopharmaceutica go up and down completely randomly.

Pair Corralation between Green Cross and Sk Biopharmaceutica

Assuming the 90 days trading horizon Green Cross Lab is expected to under-perform the Sk Biopharmaceutica. In addition to that, Green Cross is 1.18 times more volatile than Sk Biopharmaceuticals Co. It trades about -0.04 of its total potential returns per unit of risk. Sk Biopharmaceuticals Co is currently generating about 0.15 per unit of volatility. If you would invest  9,750,000  in Sk Biopharmaceuticals Co on September 20, 2024 and sell it today you would earn a total of  880,000  from holding Sk Biopharmaceuticals Co or generate 9.03% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Green Cross Lab  vs.  Sk Biopharmaceuticals Co

 Performance 
       Timeline  
Green Cross Lab 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Green Cross Lab has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Sk Biopharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Weak
Over the last 90 days Sk Biopharmaceuticals Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Sk Biopharmaceutica is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Green Cross and Sk Biopharmaceutica Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Green Cross and Sk Biopharmaceutica

The main advantage of trading using opposite Green Cross and Sk Biopharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Green Cross position performs unexpectedly, Sk Biopharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sk Biopharmaceutica will offset losses from the drop in Sk Biopharmaceutica's long position.
The idea behind Green Cross Lab and Sk Biopharmaceuticals Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets